News
Colombia issues draft decree for registration of biosimilars
2013-07-15 The Colombian Ministry of Health and Social Protection (Ministerio de Salud y Protección Social de Colombia) announced on 21 January 2013 the release of a… Read More »
When will the US biosimilars pathway be used
2013-07-12 FDA Commissioner Margaret Hamburg presented the latest statistics on the US biosimilar pathway during a speech at the Massachusetts Biotechnology Council’s (MassBio) Annual Meeting on… Read More »
Evergreening patents may make drugs too costly for patients in Thailand
2013-07-10 Many medicines will become too expensive for patients in Thailand in the near future if the government allows manufacturers to extend patents under the so-called… Read More »
Changes in risperidone use in Austria after introduction of generics
2013-07-08 Currently, many governments have introduced austerity reforms to control pharmaceutical expenditure. In Austria, efforts have been made to both increase the use and lower the… Read More »
EU API law causing concern among API producers
2013-07-05 Under the Falsified Medicines Directive the European Union (EU) is introducing new rules for importing active pharmaceutical ingredients (APIs) for human-use medicines into Europe. From… Read More »
How are biosimilars special
2013-07-03 Despite biosimilars being around in the EU since 2006 physicians are still often reluctant to prescribe them. Members and experts of the Working Party on… Read More »
Fewer generics approved in the US during 2012
2013-07-01 FDA approved fewer generics for the US market during 2012 than in 2011, according to a new report from Thomson Reuters. A total of 506 generics… Read More »
Greece says no to automatic substitution of biologicals
2013-06-28 Greece’s Medicines Agency (National Organization for Medicines, Ethnikos Organismos Farmakon, EOF) released a document on 13 March 2013 recommending against automatic substitution/interchangeability of reference biologicals and their… Read More »
Biosimilars bills move on in two US states
2013-06-26 The battle over biosimilar drugs is heating up in the US, with two states moving biosimilar bills along in the substitutability of biosimilars. In the… Read More »
Use of venlafaxine in Austria after introduction of generics
2013-06-24 Trying to reduce expenditure on medicine is a major driving force for reforms by many governments. This includes Austria, where measures have been introduced to… Read More »
